

Mylan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 120.00 Cr
- Paid Up Capital ₹ 10.00 Cr
- Company Age 28 Year, 24 Days
- Last Filing with ROC 31 Mar 2023
About Mylan Pharmaceuticals
Mylan Pharmaceuticals Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 March 1997 and has a history of 28 years. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Merck Development Centre Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 120.00 Cr and a paid-up capital of Rs 10.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mylan Pharmaceuticals Private Limited India is Rekha Lakhotiya as COMPANY SECRETARY. Ajay Rathore and Praveen Chauhan serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100TG1997PTC149781
- Company No.
106267
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Mylan Pharmaceuticals Private Limited offer?
Mylan Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Antiviral Drugs, Health Care Service, Favipiravir Tablet, Women Care, Feminine Hygiene.
Who are the key members and board of directors at Mylan Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rekha Lakhotiya ![]() | Company Secretary | 03-Dec-2015 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ajay Rathore ![]() | Whole-Time Director | 21-Jun-2019 | Current |
Praveen Chauhan ![]() | Additional Director | 22-Apr-2024 | Current |
Financial Performance of Mylan Pharmaceuticals.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Mylan Pharmaceuticals?
Unlock access to Mylan Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Related Corporates (Common Directorship)
- Famy Life Sciences Private Limited
Ajay Rathore is a mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Mylan Pharmaceuticals?
Unlock and access historical data on people associated with Mylan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Mylan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mylan Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Mylan Pharmaceuticals
Recent activity within the organization
- Director Appointment
Praveen Singh Chauhan was appointed as a Additional Director was appointed as a Additional Director on 22 Apr 2024 & has been associated with this company since 11 months 5 days .
- Annual General Meeting
Mylan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Mylan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Ajay Singh Rathore was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 21 Jun 2019 & has been associated with this company since 5 years 9 months .
- Director Appointment
Rekha Lakhotiya was appointed as a Company Secretary was appointed as a Company Secretary on 03 Dec 2015 & has been associated with this company since 9 years 3 months .
- Company Incorporation
Mylan Pharmaceuticals Private Limited was registered on 03 Mar 1997 with Roc Hyderabad & aged 28 years 24 days as per MCA records.
Recent News, Updates & Announcement
- Biocon Biologics integrates Vitaris’ biosimilars business | Mint.
The firm had acquired the American pharmaceutical company’s biosimilars business in November 2022..
- Biocon Biologics integrates Viatris' biosimilar biz in 31 European countries | Technology.
Biocon Biologics on Thursday said it has completed the integration of the acquired biosimilar business from Viatris Inc in 31 European countries.
- Matrix Labs founder buys back Viatris' API business in India.
Viatris' latest transaction includes three manufacturing sites and a R&D lab in Hyderabad, three manufacturing sites in Vizag and third-party API sales. Viatris will retain some selective R&D capabilities in API. The transaction is expected to close in Q1 2024, added Viatris' statement..
Frequently asked questions
What is the Incorporation or founding date of Mylan Pharmaceuticals Private Limited?
Mylan Pharmaceuticals Private Limited was incorporated on 03 Mar 1997.
What is authorized share capital and paid-up capital of Mylan Pharmaceuticals Private Limited?
The authorized share capital of Mylan Pharmaceuticals Private Limited is ₹ 120.00 Cr and paid-up capital is ₹ 10.00 Cr.
Who are the current board members & directors of Mylan Pharmaceuticals Private Limited?
Currently 3 directors are associated with Mylan Pharmaceuticals Private Limited.
- Ajay Singh Rathore
- Praveen Singh Chauhan
- Rekha Lakhotiya
What is the registered address of Mylan Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Mylan Pharmaceuticals Private Limited is Plot No.564/A/22 Road No.92, Jubilee Hills India, Hyderabad, Telangana, 500096.
What is the corporate identification number (CIN) and company number of Mylan Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Mylan Pharmaceuticals Private Limited is U73100TG1997PTC149781 and the company number is 106267 as per Ministry of Corporate Affairs (MCA).
What is the official website of Mylan Pharmaceuticals Private Limited?
The Official website of Mylan Pharmaceuticals Private Limited is https://www.mylan.in
When was the last Balance Sheet of Mylan Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Mylan Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
- Preetish ToraskarWholetime Director
- Marek DzikiDirector
- Ajay BhatiaWhole-Time Director
SS
Seshan SrinivasanAdditional DirectorRM
Rajiv MalikAdditional DirectorSB
Susanto BanerjeeWholetime DirectorAA
Anand ApteManaging DirectorKB
Klaus BofingerDirector